Ramadevi Subramani
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Cancer, Hypoxia, and Metabolism
- Oncology top 10%
- Cancer Cells and Metastasis
Papers in
- Oncology 16
- Pancreatic and Hepatic Oncology Research 4
- Cancer Risks and Factors 4
- Cancer-related Molecular Pathways 3
- Cancer Cells and Metastasis 3
- Cytokine Signaling Pathways and Interactions 3
- Co-authors
- Rajkumar Lakshmanaswamy (32 shared papers)Sushmita Nandy (16 shared papers)Arunkumar Arumugam (16 shared papers)Diego A. Pedroza (9 shared papers)Alok Dwivedi (4 shared papers)Elizabeth M. Gonzalez (2 shared papers)Edward C. Saltzstein (2 shared papers)Melina Sedano (2 shared papers)
- Journals
- Cancers (4 papers)Oncotarget (3 papers)Progress in molecular biology and translational science (2 papers)Cellular Physiology and Biochemistry (2 papers)Experimental & Molecular Medicine (2 papers)
- Partner nations
- United StatesIndia
In The Last Decade
Ramadevi Subramani
33 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 91
- Cancer Research 325
- Oncology 266
- Molecular Biology 565
- Endocrinology, Diabetes and Metabolism 111
- Toxicology 16
Countries citing papers authored by Ramadevi Subramani
This map shows the geographic impact of Ramadevi Subramani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ramadevi Subramani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ramadevi Subramani more than expected).
Fields of papers citing papers by Ramadevi Subramani
This network shows the impact of papers produced by Ramadevi Subramani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ramadevi Subramani. The network helps show where Ramadevi Subramani may publish in the future.
Co-authors
The 25 scholars most cited alongside Ramadevi Subramani, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 144 | |
| 2 | 2019 | 99 | |
| 3 | 2014 | 76 | |
| 4 | 2015 | 65 | |
| 5 | 2017 | 63 | |
| 6 | 2019 | 56 | |
| 7 | 2016 | 53 | |
| 8 | 2013 | 49 | |
| 9 | 2020 | 46 | |
| 10 | 2022 | 38 | |
| 11 | 2014 | 36 | |
| 12 | 2017 | 33 | |
| 13 | 2020 | 32 | |
| 14 | 2021 | 32 | |
| 15 | 2015 | 31 | |
| 16 | 2020 | 27 | |
| 17 | 2021 | 27 | |
| 18 | 2017 | 26 | |
| 19 | 2017 | 26 | |
| 20 | 2018 | 21 |
About Ramadevi Subramani
Ramadevi Subramani is a scholar working on Molecular Biology, Oncology, Cancer Research, Endocrinology, Diabetes and Metabolism and Genetics, having authored 33 papers that have together received 1.1k indexed citations. Recurring topics across this work include Growth Hormone and Insulin-like Growth Factors (5 papers), Cancer, Hypoxia, and Metabolism (5 papers), Estrogen and related hormone effects (4 papers), Pancreatic and Hepatic Oncology Research (4 papers), Cancer Risks and Factors (4 papers), Cancer-related Molecular Pathways (3 papers), Cancer Cells and Metastasis (3 papers) and Cytokine Signaling Pathways and Interactions (3 papers). The work is most often cited by research in Cancer Research (325 citations), Oncology (266 citations), Molecular Biology (565 citations), Endocrinology, Diabetes and Metabolism (111 citations) and Toxicology (16 citations). Ramadevi Subramani has collaborated with scholars based in United States and India. Frequent co-authors include Rajkumar Lakshmanaswamy, Sushmita Nandy, Arunkumar Arumugam, Diego A. Pedroza, Alok Dwivedi, Elizabeth M. Gonzalez, Edward C. Saltzstein, Melina Sedano, Enrique Ramos and Ramesh Choudhari. Their work appears in journals such as Cancers, Oncotarget, Progress in molecular biology and translational science, Cellular Physiology and Biochemistry and Experimental & Molecular Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.